AstraZeneca lifts 2005 hopes after in-line 2004
AstraZeneca Plc said on Thursday strong demand for established medicines and cost cuts would help it overcome recent setbacks to newer drugs, boosting its shares as it reported an expected rise in 2004 earnings. Europe's third-biggest drugmaker, whose sha